As the world’s largest funder of cancer research, NIH research grants have made it possible to extend countless lives and notably reduce cancer development and death. We can also thank NIH-funded rese...

Endocrine therapy was associated with a greater reduction in HRQOL, as measured by GHS, compared with radiotherapy at 24 months. While these interim results suggest radiotherapy might better preserve HRQOL in older women with low-risk early breast cancer, further data on disease control outcomes and final patient accrual are needed to draw definitive conclusions.

During his second day of confirmation hearings, Robert F. Kennedy Jr. declined to disavow comments he had made disparaging the vaccine as unsafe.

In "remarkable" work, a patch of engineered heart muscle cells was used to strengthen a patient's heart before transplant.

The radiobiological basis of hypofractionation pivots on two fundamental tumour characteristics - low α/β ratio and high repopulation factor. In our w…

If you’re fed up with Meta right now, you’re not alone. Meta tracks you across millions of websites and apps and its business model relies on your data. If you want to limit Meta’s ability to collect ...

Yvonne Mowery, MD, PhD, discusses the SU2C-SARC032 trial of pembrolizumab plus radiotherapy followed by surgery in soft tissue sarcoma.

Monday mutterings The human body Does not want to lose weight. It does not like to shed what millions of years have made it capable of, making padding from scraps I know this society praises the....

The medical physicists Eric Ford and Afua Yorke are our podcast guests

Background: The incidence and mortality of anal squamous cell carcinoma (ASCC) are rising, with greater than 80% of cases linked to human papillomavirus (HPV), primarily HPV16. Post-treatment surveill...

Our findings provide the strongest level of evidence so far to the magnitude of the benefit of ADT treatment intensification with radiotherapy for men with localised prostate cancer. Adding ADT and prolonging the portion of ADT that follows radiotherapy is associated with improved metastasis-free survival in men, regardless of risk group, age, and radiotherapy dose delivered; however, the magnitude of the benefit could vary and shared decision making with patients is recommended.

Mark Lythgoe: Subcutaneous nivolumab approved by FDA Oncology across all indications / atezolizumab, biosimilars, cancer, FDA, Mark Lythgoe, nivolumab,